AboutBlogOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs

483 Braintree, A part of SEBELA Pharmaceuticals, Oct 2019

$119 - Available for instant download

FDA investigators audited the Braintree, A part of SEBELA Pharmaceuticals - Holbrook , MA, United States facility and issued inspectional observations (via FDA 483) on 22 Oct 2019.

Product Details

  • Category: Human Drugs
  • Inspection end: 22 Oct 2019
  • Location: Holbrook, United States
  • FEI: 1000513636
Braintree, A part of SEBELA Pharmaceuticals FDA inspection 483 Oct 2019